VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, ...

Psilocybin has appeared in a number of biotech pipelines as the sector investigates whether psychedelics could improve treatment for certain mental health conditions. Relmada Therapeutics’ attempts to ...

Toronto, Ontario--(Newsfile Corp. - June 7, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland"), a company engaged in the production, growth, and sale of ...

The approval to initiate this Phase 2 clinical trial represents a pivotal moment in the clinical development of Optimi's GMP natural psilocybin extract capsules. Building on its established status as ...

A strength of the study is the comparison of psilocybin to psychedelic mushroom extract (PME). This is because psilocybin mushrooms also contain a host of biologically active compounds (such as ...

VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, ...

Colorado could limit the state’s emerging magic mushroom industry to one strain and severely restrict the use of psilocybin extractions, according to the final draft of proposed natural medicine ...

For centuries, indigenous cultures across Mexico and Central America have used Psilocybe mushrooms in their healing ceremonies. Today, those same fungi are being explored as a treatment for ...

“We are in the middle of a rapidly evolving cultural, media, and legal landscape when it comes to psychedelics,” says Nora D. Volkow, M.D., director of the National Institute on Drug Abuse (NIDA).

As many states and municipalities around the country grapple with the ever-increasing popularity of psilocybin-based products, a few have staked out leading positions in what may be the next wave of ...